Candriam S.C.A. Lantheus Holdings, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 118,007 shares of LNTH stock, worth $11.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

118,007

Previous 224,530 47.44%

Holding current value

$11.5 Million

Previous $18 Million 28.16%

% of portfolio

0.08%

Previous 0.11%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$77.7 - $123.62 $8.28 Million - $13.2 Million	-106,523 Reduced 47.44%	118,007 $13 Million
Q2 2024 Aug 05, 2024	SELL	$58.87 - $83.05 $10.7 Million - $15.1 Million	-182,223 Reduced 44.8%	224,530 $18 Million
Q1 2024 May 03, 2024	SELL	$51.07 - $68.26 $3.9 Million - $5.21 Million	-76,335 Reduced 15.8%	406,753 $25.3 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $1.74 Million - $2.44 Million	-31,373 Reduced 6.1%	483,088 $30 Million
Q3 2023 Nov 13, 2023	BUY	$60.27 - $90.75 $2.47 Million - $3.72 Million	40,987 Added 8.66%	514,461 $35.7 Million
Q2 2023 Aug 08, 2023	BUY	$82.41 - $99.65 $4.8 Million - $5.81 Million	58,265 Added 14.03%	473,474 $39.7 Million
Q1 2023 May 12, 2023	BUY	$47.76 - $82.86 $19 Million - $33 Million	398,823 Added 2433.93%	415,209 $34.3 Million
Q4 2022 Feb 13, 2023	BUY	$48.76 - $77.67 $200,354 - $319,146	4,109 Added 33.47%	16,386 $835,000
Q3 2022 Nov 10, 2022	SELL	$61.42 - $86.29 $1.17 Million - $1.65 Million	-19,082 Reduced 60.85%	12,277 $863,000
Q2 2022 Aug 03, 2022	BUY	$55.54 - $72.65 $1.41 Million - $1.85 Million	25,410 Added 427.13%	31,359 $2.07 Million
Q1 2022 May 13, 2022	BUY	$24.28 - $56.64 $144,441 - $336,951	5,949 New	5,949 $329,000

Others Institutions Holding LNTH

# of Institutions

538

Shares Held

68.4M

Call Options Held

679K

Put Options Held

423K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account